BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Griffith joins $280 million partnership to deliver mRNA vaccine outcomes

The $280 million Translational Science Hub will be established under an agreement between Sanofi, Griffith University, the University of Queensland and the...

December 05, 2022 | News

How Optoacoustic Imaging Plays a Role in Assessing the Success of Breast Cancer Surgery

This first-in-human study was carried out by a team of researchers and clinicians at A*STAR’s Institute of Bioengineering and Bioimaging (IBB)&...

December 05, 2022 | News

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that ...

December 02, 2022 | News

MGI Cements Its Presence and Contribution in Singapore's Genomics Landscape at ESMO Asia Congress 2022

At ESMO, MGI sets to showcase its MGISP-100 Automated Sample Preparation System and DNBSEQ-G99* Genetic Sequencer at Booth C209. Suitable for small and med...

December 02, 2022 | News

New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio

ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual ...

December 01, 2022 | News

XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development

AI-driven drug research and development (R&D) is breaking new ground, providing faster and more effective treatment options for more patients worldwide...

November 25, 2022 | News

Australian Scientists Honoured with the Grand Hamdan Award

The Award ceremony of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, hosted in Dubai, took place on 23rd of ...

November 25, 2022 | News

AcuCort signs its first commercial agreement for the company's drug Zeqmelit™

Kamada Ltd., a leading global biopharmaceutical company, has a well-established infrastructure for marketing, sales, and distribution of commercial pharmac...

November 24, 2022 | News

Cellworks Therapy Biosimulation Study Reveals Promising New Biomarkers for TMZ Resistance in Glioblastoma Patients

Cellworks Group Inc., a leader in Precision Drug Development and Personalized Therapy Biosimulation, today announced results from a Cellworks biosimulation...

November 23, 2022 | News

GSK opens first-in-Singapore high potency manufacturing and testing facility for next generation cancer treatments

S$44m investment in the new high potency manufacturing facility and laboratory further strengthens Jurong site capabilities to launch new products more q...

November 21, 2022 | News

New CRISPR/Cas9 Agreement for ERS Genomics and ATLATL

ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual ...

November 18, 2022 | News

Ascletis Announces IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors by China NMPA

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today the approval of the Investigational New Drug (IND) application by China National Medical Prod...

November 17, 2022 | News

Standigm Synthetic Research Center successfully accelerates drug discovery in its first year

Standigm, the workflow AI-driven drug discovery company, today announced the celebration of its Synthetic Research Center's first year. In the last 12 mont...

November 17, 2022 | News

Simcere and Idorsia enter into a licensing agreement for daridorexant in China

Jinsheng Ren,Chairman and CEO of Simcere commented: "This licensing agreement represents an important and exciting step in pursuing Simcere's mission of p...

November 16, 2022 | News

Stay Connected